按绩效支付的风险分担协议在医疗器械领域的应用与展望

Application and Prospect of Payment for Performance Risk-Sharing Arrangements for Medical Device in China

医疗器械在快速发展的同时,可能存在疗效不确定的问题,按绩效支付的风险分担协议有助于消除支付方和医疗机构对不确定性的担忧。本研究总结了国内外在医疗器械领域应用按绩效支付风险分担协议的案例,梳理了医疗器械领域实施按绩效支付的关键考量因素,包括需要紧密结合管理政策、满足不同利益相关方的需求、选定适宜的医疗器械和实施范围、做好协议设计与落地执行。基于国内外的应用经验和政策现状,本文对按绩效支付风险分担协议推动我国医疗器械价值准入、支持DRG/DIP下的创新医疗器械使用提出了展望探讨。

Rapid development of medical devices introduces the concern of value uncertainty, and payment for performance risk-sharing arrangements(RSA) can help address uncertainty concerns of payers and medical institutions. This study summarized the payment for performance RSA cases for medical devices both at home and abroad, and analyzed key elements to be considered in medical devices payment for performance, including closely combining with healthcare policies, satisfying key stakeholders’ needs, selecting proper medical devices and scope, and establishing RSA scheme design and implementation. Based on local and global experience as well as current policy, this paper analyzed the application and prospect of payment for performance RSA to support the value access for medical devices and promote the use of innovative medical devices in the context of DRG/DIP in China.